Members may be aware of updates to the UK policies as they have been ˜agged in
the National News Media. The Energy White Paper ‘Powering our Way to a Net Zero
Future’ was issued on Monday (14th December) and is available on the BASA
website on the Environment & Sustainability Working Group page. This sets out the
strategic direction the government is taking in relation to energy supplies, transport
etc. See pages 96 to 117 for Buildings, and 118 to 131 for industrial energy.
Included in the Energy White Paper and announced at the London Stock Exchange
at 7am on Monday was the decision that the UK government and the devolved
administrations will implement a UK Emissions Trading Scheme from 1st January
2021, all the necessary legislation has already passed through Parliament. This is a
decision away from a general carbon tax. The government hopes that in time the
UKETS will link to the EU Emissions Trading System (EUETS).
In other news the Sixth Carbon Budget report was published by the Climate
Change Committee on 9th December 2020 and is based on an extensive
programme of analysis, consultation and consideration by the Committee and its
sta° , building on the evidence published last year for our Net Zero advice, again the
report can be downloaded via the E&S WG pages and is taken from the CCC
website: https://www.theccc.org.uk/publication/sixth-carbon-budget/
In support of the advice in this report, there is also a Methodology Report, setting
out the evidence and methodology behind the scenarios and a Policy Report,
setting out the changes to policy that could drive the changes necessary
particularly over the 2020s. The charts and data behind the report are available, as
well as a separate dataset for the Sixth Carbon Budget scenarios and a public Call for
Evidence. The recommended pathway requires a 78% reduction in UK territorial
emissions between 1990 and 2035. In e° ect, bringing forward the UK’s previous
80% target by nearly 15 years.
INFORMED COMMENT FROM THE BRITISH ADHESIVES & SEALANTS ASSOCIATION
@
@BASA_updates www.basa.uk.com +44 3302 233290 secretary@basa.uk.com
Bulletin
Issue 91
FEBRUARY 2021
Online
INSIDE THIS ISSUE:
HSE spot checks and
inspec�ons on businesses
con�nue during lockdown
RIDDOR repor�ng of
COVID-19
Tes�ng Times The
Logis�cs and Benefits of
Workplace Tes�ng for
COVID-19: Hampton Knight
Feeling the post-Brexit heat
of the new wooden Pallet
requirements: DAERA
HMCA Medical Cover for
BASA Members
Does the pandemic spell
the end of tradi�onal
silicone sanitary sealants?
Hodgson Sealants
Apollo Technical Centre
anniversary
4Ward Tes�ng completes
UKAS reassesment
CPG UK puts £9,000
budgeted for Christmas to a
pioneering community
project
Chemique Adhesives
publish Technical Paper
Coronavirus effect on
supply chains: JOC
Bondloc UK Ltd
Renews ISO 9001:2015
Cer�fica�on
Climate Change, Decarbonisation and Net Zero
02
04
05
08
09
10
11
11
12
13
13
14
Continued on next page.
____________________________________________
_____
________________________________________________
| BASA BULLETIN Issue 91 www.basa.uk.com
Also published on 3rd December was a press release setting
ambitious new climate target ahead of UN Summit with the
plan aiming for at least 68% reduction in greenhouse gas
emissions by the end of the decade, compared to 1990 levels.
This plan commits the UK to reducing emissions by the
fastest rate of any major economy, ahead of the Climate
Ambition Summit later this month.
The plan is backed by the Prime Ministers Ten Point Plan for
a green industrial revolution, which will create and support
up to 250,000 British jobs by 2030. The plan sets out
ambitious policies and investment, with the potential to
deliver over £40 billion of private investment by 2030, so that
we can develop innovative technologies and make
signicant strides in cutting emissions across energy,
transport and buildings. It also provides a roadmap of further
action the UK will be taking to reduce emissions in the
coming decades, encouraging similar levels of ambition from
businesses, organisations and nations around the world.
The Department for Business, Energy and Industrial Strategy
(BEIS) has extended the CCA scheme for 2 years, until March
2025. Climate change agreements are voluntary agreements
made between UK industry and the Environment Agency to
reduce energy use and carbon dioxide (CO2) emissions. In
return, operators receive a discount on the Climate Change
Levy (CCL), a tax added to electricity and fuel bills. The
Environment Agency administers the CCA scheme on behalf of the whole of the UK.
With the high number of coronavirus cases, and national
lockdown restrictions in place, all businesses that
continue to operate must ensure their workplace is
COVID-secure.
During lockdown, the Health and Safety Executive (HSE) will
be increasing the number of COVID-secure spot checks and
inspections they carry out on businesses to check they have
measures in place to manage the risk from coronavirus.
Employers must make sure that everyone is following the
measures that have been put in place to manage the risks of
transmission of COVID-19.
During the calls and visits, HSE provides advice and guidance
to manage risk and protect workers and visitors. Where
businesses are not managing this, we will take immediate
action. This can range from the provision of specic advice,
issuing enforcement notices, stopping certain work practices
until they are made safe and, where businesses fail to comply,
this could lead to prosecution.
Being COVID-secure means businesses need to keep up to date
with the latest guidance and put measures in place to manage
the risk and protect workers, visitors and customers.
Please ensure your workplace is safe by following the guidance
on being COVID-secure. Further information on spot checks
and inspections is available on our website.
Clinic
Every Friday, 10am
Microsoft Team link at
www.basa.uk.com/home/events
The BASA Secretariat including
the BASA consultants run a 30
minute clinic every Friday at 10:00
to present important Brexit
information and guidance and to
give BASA members an opportunity
to ask questions.
We may be unable to answer the
questions live - but all questions will
be resolved after consultation with
the relevant government contacts.
Please join us to ask your questions.
This is a fixed invitation so why not
add as a recurring calendar entry.
WELCOME
www.basa.uk.com BASA BULLETIN Issue 91 | 3
Since the last BASA Bulletin in December, sent out by post to
all current BASA Member Companies and available online
on the website, the world has changed in ways that many
might not have predicted. We are seeing the signicant
rollout of the COVID vaccine and we all hope that this might
bring back some sort of normality to the business world by
the Summer and we have now nally left the EU.
The last-minute Trade deal with the EU delivered Tari free
trade, but without the convenience of EU Membership to
avoid tricky rules of origin and a myriad of additional
administrative issues.
Those Member companies who were familiar with Third
Country export (i.e., export to non-EU countries), would be
familiar with the processes, but may not have realised that
the actual taris will change as the UK no longer benets
from any EU trade deals. In addition, the rules of origin come
into play, something that BASA focussed on during our
November 2020 Open Industry Forum, to benet from no
tari when exporting to the EU you must be able to show UK
origin. The use of appropriate Commodity codes is vital, we
are trying to put some guidance together with the common
codes to help less experienced member companies.
We cannot escape the challenge that the introduction of UK
REACH brings and BASA continues to run a FREE 30 minute
(and sometimes longer!) BASA Q&A Clinic every Friday at
10:00. This is an informal session to ask questions and discuss
issues, we have been lucky to have representatives form
both BEIS and DEFRA this year to supplement BASA
Consultants. The joining instructions for Member companies
only are available on the website.
We are currently putting some simple guidance together on
UK REACH, UKCA Marking, Poisons centres and SCIP, so make
sure you have access to the BASA website to get alerts as
soon as this is available.
Finally, we are looking to run the AGM as a short Webinar on
the original date of Wednesday 24th March 2021 including
a couple of good speakers and another virtual Open
Industry Forum provisionally on March 10th 2021, so please
keep an eye out for more information and try to join us. If any
Member Company would like to sponsor a paid speaker for
the AGM then please contact me to discuss.

 



Email: secretary@basa.co.uk
| BASA BULLETIN Issue 91 www.basa.uk.com
In response to the coronavirus pandemic, the Health
and Safety Executive introduced new guidance
requiring employers to report conÿrmed cases of
COVID-19 within the workplace under the Reporting
of Injuries, Diseases and Dangerous Occurrences
Regulations 2013 (‘RIDDOR’) where there is
reasonable evidence that ‘a work-related exposure is
the likely cause of the disease.
The guidance states that you should make a report
when one of the following circumstances applies:
1) an incident or accident at work has, or could
have, led to the release or escape of coronavirus.
This must be reported as a dangerous occurrence.
2) a worker or an employee has been diagnosed as
having COVID-19, and that diagnosis has been
attributed to their work. This should be reported as
a case of disease.
3) a worker or an employee dies as a result of
COVID-19, having been exposed to the virus
through their work. This should be reported as a
work-related death due to exposure to a biological
agent.
For the majority of employers, scenarios 2 and 3 are
likely to be of most relevance.
While this may all sound straightforward, in the context
of a global pandemic how can you be sure that an
employee has contracted the virus through workplace
exposure,
rather than as a result of their
social interactions
outside of work?
The HSE is clear that there is no requirement for RIDDOR
reports to be submitted on a precautionary basis where
there is no evidence to suggest that occupational
exposure was the likely cause of an infection'.
It also states that employers do not need to conduct
extensive enquiries in seeking to determine whether a
COVID-19 infection is work-related’ but should make a
judgement as to whether it is more likely than not that
the persons work was the source of exposure on the
basis of the information available. The below chart
provides a basic summary of these points.
Clearly, the key question for employers is whether or not
an employees work activities put them at increased risk
of becoming exposed to coronavirus. When considered
in this light, its easy to see how regular workplace
testing for COVID-19, when combined with robust
infection and prevention control measures, can help to
reduce uncertainty around RIDDOR reporting by giving
you greater reassurance that your employees are
protected as far as possible from exposure to the virus
when they come to work.


If something happens
at work which results
in [or could result in]
the release or escape
of coronavirus*
Report as a Dangerous
Occurance -
regulation 7.
Schedule 2 - Section
10 on
legislation.gov.uk
Member of sta° dies as
a result of COVID-19
Has a registered medical
practitioner conÿrmed
COVID-19 / Coronavirus
as the likely cause of
death
Yes
Yes
Yes
No
No
No
Is there reasonable
evidence**
suggesting that a
work-related exposure to
coronavirus was the likely
cause of death
Report as a Work
Related Fatality -
Regulation 6 [2] on
legislation.gov.uk
Not RIDDOR
reportable for
COVID-19 /
Coronavirus
Member of sta° t ests
positive for COVID-19
Report as Cases of disease:
exposure to a biological agent -
Regulation 9 [b] on
legislation.gov.uk
Not RIDDOR
reportable for
COVID-19 /
Coronavirus
Is there reasonable evidence**
suggesting that a work-related
exposure was the likely cause of
the member contracting
COVID-19
Not RIDDOR
reportable for
COVID-19 /
Coronavirus
WHEN IS CORONAVIRUS/COVID-19 RIDDOR REPORTABLE?
*
A labatory worker accidentally smashes a vial containing coronavirus on the oor
(i.e. outside of a microbiological safety cabinet), leading to people being exposed.
**
For further guidance on making a judgement and using reasonable evidence
please refer to the Health and Safety Executive Website.
www.basa.uk.com BASA BULLETIN Issue 91 | 5
While the rollout of the COVID-19 vaccine is now well
underway and o° ers a source of great hope in the
ongoing ÿght against coronavirus, it could take up to a
year before everyone is vaccinated.
In the meantime, infection rates remain dangerously high
and the pandemic continues to pose signiÿcant
challenges for businesses tasked with trying to keep their
operations on track while ensuring that employees who
cannot work from home stay protected from exposure to
the virus.
Against this backdrop, introducing a workplace testing
programme for COVID-19 could be the answer to
preserving and enabling business continuity for many
organisations. Although it should not be considered a
substitute for carrying out comprehensive risk
assessments and implementing robust protective
measures, which remain the best defence against
transmission, workplace testing can o° er an additional
level of protection for your teams and allow your business
to continue operating safely.
Stopping the Spread – How workplace testing helps
you keep your business COVID-secure
Corporate testing allows you to test all employees, even
those who may be asymptomatic or pre-symptomatic.
When you consider that most people only start to display
symptoms between 2-14 days after contracting the virus,
and around 78 per cent of people infected with COVID-19
never show any symptoms at all, the beneÿts of this are
obvious. Identifying infected individuals at an early stage
means you can take immediate steps to isolate them,
leaving less opportunity for them to unknowingly spread
the virus among their colleagues and reducing the
number of employees having to isolate unnecessarily.
Testing your employees also o° ers a range of other
beneÿts, enabling you to:
create COVID-secure cohorts, or workplace ‘bubbles’ – this
is particularly important in situations where close-contact
working is unavoidable and other preventative measures
(such as social distancing) are unfeasible
• test employees who need to travel outside of the UK for
work and are required to provide evidence of a negative
COVID-19 test result upon departure/arrival
• reduce disruption and limit any impact on your
absence and productivity levels
• give your employees peace of mind
Making it work for your business - Key considerations
What are you looking to achieve through testing?
You will need to decide:
who to test – all employees, or only those with
symptoms? What about contractors?
• how frequently to test
• what type of test to use – you should only use quality
assured testing kits that have been approved by the
Medicines and Healthcare Products Regulatory Agency
(MHRA) and carry the CE mark
How will you use the results?
You will need to think about:
• how you will communicate your testing programme to
your employees and what the arrangements will be for
any individual who does not wish to be tested
• how you will handle health information and
communicate positive results to the employee concerned,
as well as to those they have been in contact with
how the results will be reported to Public Health England
(PHE)
• whether your testing programme is compatible with
your existing legal obligations to your employees,
including those relating to health and safety, equalities,
data protection and employment law. Will you need to
put additional speciÿc policies and procedures in place?
Does your workplace have appropriate facilities for
testing?
You should also be clear on the potential costs of
implementing a testing programme (which can be
signiÿcant) and the limitations of testing.

 

| BASA BULLETIN Issue 91 www.basa.uk.com
With so much to think about, and such a wide range of
testing options available, it is highly recommended
that you seek professional advice and guidance from a
reputable testing provider before you embark on a
workplace testing programme, so you can be sure that
you are choosing the best possible approach for your
organisation.
With Hampton Knight’s robust testing service, you
can rest assured youre in safe hands
Hampton Knight, now part of the Medigold Health
Group, have been delivering market-leading workplace
trained and qualied professional and it is
recommended that any positive results are
subsequently conrmed with a RT-PCR test and
laboratory analysis.
No matter which type of antigen test you choose to
use, samples should always be analysed and
interpreted by trained and qualied healthcare
professionals. Use of self-testing kits is only permitted
where the process is to be overseen by a healthcare
professional.
A word on COVID-19 Antibody Testing
Hampton Knight do not oer COVID-19 antibody
testing; due to the current uncertainty surrounding
how long immunity resulting from prior exposure to
coronavirus may last, there is no strong evidence to
support its use in workplace settings.
Testing thats tailored to your business
Hampton Knight work in consultation with all clients to
understand their specic needs and help them
determine the most appropriate testing solution for
their business. Their high-quality, fully-managed
service features:
Scalable solutions and exible delivery
• Expert collection technicians can carry out testing
onsite, at Medigold Health clinics or as a doorstop
test. Mobile units are available if you do not have
suitable testing facilities at your locations.
• Onsite sampling allows large numbers of
employees to be eciently tested in each session
(technicians can conduct up to 40 RT-PCR swab tests
or 30 rapid LFD tests per day). One-o and
short-notice requests can also be accommodated,
where required.
Technicians are equipped with full PPE and
approved testing kits.
• Self-collection kits can be provided (for RT-PCR
swab tests only) as an alternative to onsite testing.
Kits are designed to enable employees to follow
secure sampling protocols with no training required
and contain everything needed to collect, package
and ship samples to the laboratory for testing.
• If you already have government-supplied rapid LFD
testing kits, we can provide training, guidance, and
clinical support, on-site or online, to ensure your
testers are performing tests accurately.
Rapid turnaround times
• Hampton Knights dedicated team are available
24/7 to manage bookings and carry out onsite and
alcohol and drug screening services for over 20 years
and already had established relationships with a
number of private PHE and UKAS approved
laboratories, along with a substantial, UK-wide
network of specialist collection technicians.
With the onset of the coronavirus pandemic, they
were able to quickly pivot their operations, training
their technicians in the COVID-19 sampling process
and investing signicantly in developing their
infrastructure to support even larger-scale testing.
Committed to ensuring that they remain at the
forefront of COVID-19 testing, they have already
completed the rst phase of the Approved Provider
accreditation process and their clinical governance
team collaborate regularly with a number of UK
working groups.
Since May 2020, they have carried out over 23,000
tests for clients across multiple industry sectors, from
broadcasting to transport and logistics.
Keeping it Simple – Reliable, eective antigen
testing
Hampton Knight oer two types of COVID-19
(SARS-CoV-2) antigen test, both of which can
eectively detect the presence of the live virus to
conrm whether an individual is infectious, even if
they are asymptomatic.
COVID-19 RT-PCR Antigen Swab Test
With 99 per cent accuracy, this type of test represents
the gold standard’ for COVID-19 testing. A throat and
nasal swab is used to collect a sample, which is then
sent to a laboratory for analysis, and results are
returned within 48 hours. Tests are usually carried out
by one of Hampton Knights specialist collection
technicians, but clients can also choose to purchase
self-collection kits that their employees can use to
collect their own samples at home.
Rapid Lateral Flow Antigen Test
Rapid testing is carried out using a throat and nasal
swab sample, which is then processed using an
extraction uid and a lateral ow device (LFD). This
type of test can produce results within 15-20 minutes
without the need for laboratory analysis. LFD tests are
signicantly cheaper than RT-PCR tests, but they also
have lower levels of sensitivity, meaning they may
produce more false negative results, particularly in
asymptomatic individuals. This risk can be mitigated
through more frequent testing. LFD tests should only
be carried out by, or under the supervision of, a fully
doorstep visits.
Visits can be scheduled, and self-collection kits
shipped, with just 48 hours notice.
• Rapid LFD tests return results within 15 minutes.
• RT-PCR swab samples are sent for analysis via
same-day specialist medical courier or can be
shipped free of charge within 24 hours via Royal
Mail’s NHS Priority Mailbox network.
• Labs operate 24/7 to ensure RT-PCR results are
returned within 48 hours of receipt.
Clear reporting and end-to-end support
• Hampton Knight oer a fully managed service that
incorporates the reporting of all test results to SGSS
at PHE, in accordance with government guidelines.
• RT-PCR swab test results are returned to employers
securely via email in a GDPR-compliant and
easy-to-interpret format, indicating either a positive,
negative, or inconclusive result.
• Specialist Occupational Health Clinicians are on
hand to provide medical guidance and ongoing
clinical support in all cases where a positive result is
recorded.
• Clients are provided with regular management
information reports and access to supplementary
resources, documentation, information sheets and
training to support eective use of the service.
For more information on how Hampton Knight can
support your business with COVID-19 testing, please
contact salesenquiries@hamptonknight.co.uk or
call 01827 338700.
Helpful resources:
Testing Accuracy: The low-down on specicity
and sensitivity
The accuracy of dierent types of COVID-19 test is
determined by two factors:
Specicity: if a test has high specicity, when a
positive result is returned, there is a high likelihood
of it being a true positive, i.e. the person is likely to
have Covid-19.
Sensitivity: if a test has high sensitivity, it is more
likely to pick up the virus in an infected person i.e.
there is less likelihood of it returning a false
negative.
No test is one hundred per cent accurate and
false positives and (more problematically) false
negatives do occur.
In some cases, tests may even return an
inconclusive result, meaning the laboratory has
been unable to determine whether or not a person
is infected with Covid-19 following analysis of the
sample provided, and a repeat test will be required.
It is also important to remember that if someone
tests negative for Covid-19, this simply means they
were at low risk of having the virus on the day they
gave their sample. It is still possible that they may
have subsequently been exposed to the virus since
being tested and could still test positive later.
Ensuring that tests are carried out regularly and
conducted by trained specialists is the best way to
guarantee that samples are t for analysis, reduce
the risk of false positive and negative results, and
get the best from your testing programme.
www.basa.uk.com BASA BULLETIN Issue 91 |
With so much to think about, and such a wide range of
testing options available, it is highly recommended
that you seek professional advice and guidance from a
reputable testing provider before you embark on a
workplace testing programme, so you can be sure that
you are choosing the best possible approach for your
organisation.
With Hampton Knight’s robust testing service, you
can rest assured youre in safe hands
Hampton Knight, now part of the Medigold Health
Group, have been delivering market-leading workplace
trained and qualied professional and it is
recommended that any positive results are
subsequently conrmed with a RT-PCR test and
laboratory analysis.
No matter which type of antigen test you choose to
use, samples should always be analysed and
interpreted by trained and qualied healthcare
professionals. Use of self-testing kits is only permitted
where the process is to be overseen by a healthcare
professional.
A word on COVID-19 Antibody Testing
Hampton Knight do not oer COVID-19 antibody
testing; due to the current uncertainty surrounding
how long immunity resulting from prior exposure to
coronavirus may last, there is no strong evidence to
support its use in workplace settings.
Testing thats tailored to your business
Hampton Knight work in consultation with all clients to
understand their specic needs and help them
determine the most appropriate testing solution for
their business. Their high-quality, fully-managed
service features:
Scalable solutions and exible delivery
• Expert collection technicians can carry out testing
onsite, at Medigold Health clinics or as a doorstop
test. Mobile units are available if you do not have
suitable testing facilities at your locations.
• Onsite sampling allows large numbers of
employees to be eciently tested in each session
(technicians can conduct up to 40 RT-PCR swab tests
or 30 rapid LFD tests per day). One-o and
short-notice requests can also be accommodated,
where required.
Technicians are equipped with full PPE and
approved testing kits.
• Self-collection kits can be provided (for RT-PCR
swab tests only) as an alternative to onsite testing.
Kits are designed to enable employees to follow
secure sampling protocols with no training required
and contain everything needed to collect, package
and ship samples to the laboratory for testing.
• If you already have government-supplied rapid LFD
testing kits, we can provide training, guidance, and
clinical support, on-site or online, to ensure your
testers are performing tests accurately.
Rapid turnaround times
• Hampton Knights dedicated team are available
24/7 to manage bookings and carry out onsite and
doorstep visits.
Visits can be scheduled, and self-collection kits
shipped, with just 48 hours notice.
• Rapid LFD tests return results within 15 minutes.
• RT-PCR swab samples are sent for analysis via
same-day specialist medical courier or can be
shipped free of charge within 24 hours via Royal
Mail’s NHS Priority Mailbox network.
• Labs operate 24/7 to ensure RT-PCR results are
returned within 48 hours of receipt.
Clear reporting and end-to-end support
• Hampton Knight oer a fully managed service that
incorporates the reporting of all test results to SGSS
at PHE, in accordance with government guidelines.
• RT-PCR swab test results are returned to employers
securely via email in a GDPR-compliant and
easy-to-interpret format, indicating either a positive,
negative, or inconclusive result.
• Specialist Occupational Health Clinicians are on
hand to provide medical guidance and ongoing
clinical support in all cases where a positive result is
recorded.
• Clients are provided with regular management
information reports and access to supplementary
resources, documentation, information sheets and
training to support eective use of the service.
For more information on how Hampton Knight can
support your business with COVID-19 testing, please
contact salesenquiries@hamptonknight.co.uk or
call 01827 338700.
Helpful resources:
| BASA BULLETIN Issue 91 www.basa.uk.com
Importers of goods of all kinds with wood packaging
material which includes solid wood pallets and wood to
support goods during transport need to be aware that
there are import requirements. This is because wood
packaging material is a known pathway for the
introduction of harmful tree and forestry pests and
diseases.
EU regulations on third country imports stipulate that
wood pallets must be heat-treated or cleaned to prevent
contamination and the spread of pests and have specic
markings to conrm that they are legal in EU markets. Solid
wood packaging must meet the ISPM15 international
standards if you import it from outside the EU.
If you import from the EU
(except Portugal), you can
specify less strict standards.
Packaging can either be
bark-free or have a plant
passport if its made out of
conifer wood. If its kiln dried,
it must also be marked ‘KD.
According to the Timber
Packaging and Pallet
Confederation, Britain does
not have enough of the right
sort of disease-resistant
pallets to trade with the
European Union in future - a
situation that, ironically, has
been made worse by the
pandemic.
Wooden pallets need to be
baked at 56C, ensuring that




they meet the requirements of a regulation known as ISPM 15
but for the purposes of world trade, the EU is treated as one
country and therefore it has not mattered whether wooden
pallets going between Britain and the Continent are certied
to ISPM 15 standards. From 1st January 2021 this has changed
as eectively the UK is now a
Third Country and is subject
to the same rules as all non-EU countries.
Because of the Northern Ireland protocol and the
requirement for unfettered access, exporters of goods of all
kinds with wood packaging material (WPM) from the GB to NI
will need to be aware of the requirement to treatment by one
of the approved measures specied in ISPM15 (Revised 2009)
for landing them in Northern Ireland.
Further information about Northern Ireland landing
requirements for wood, wood products, wood packaging and
bark is available from DAERA Forest Service Plant Health
Inspection Branch:
Web page:
• Email: forestwoodbarkphi@daera-ni.co.uk
Tel: 028 9052 4168
Call today for a no obligation quote:
or enquire online at: www.hmca.co.uk/basa
This advertisement is produced and presented by HMCA/S PLC (trading as Hospital Medical Care Association, HMCA and HMCA Members) which is authorised
and regulated by the Financial Conduct Authority (FRN:307587). HMCA/S PLC is a company registered in England, company number: 01362094, registered
oce: Beech Hall, Knaresborough, North Yorkshire, HG5 0EA
Special Oer
Up to
40%
discount for members of
British Adhesives and
Sealants Association
Do you have
Private Medical Cover?
Transfer & Save with HMCA
Our Private Medical Plans
Your choice of hospital & specialist
NHS queues avoided
No age limit
Tax free NHS cash benet
Claims settled promptly
Excellent UK based service
*
*This discount is also available to you if you do not presently have private medical cover.
01423 799949
www.basa.uk.com BASA BULLETIN Issue 91 | 9
| BASA BULLETIN Issue 91 www.basa.uk.com


• Oxidative damage: Antimicrobial products can
cause increased levels of reactive oxygen species,
which result in damage to the internal systems of
the microbe.
• DNA interference: The genetic material of the
bacteria is disrupted, ultimately stopping the
bacteria from being able to replicate by blocking
the copying of their genetic material.
That all sounds great but we can prove it works
because our antimicrobial products have been tested
by 3rd party labs to show a reduction of MRSA and E.
Coli microbes by up to 99.99%. Hybrid polymers
typically have far greater performance capabilities
with much greater bond strength and exibility. This
“hardness can also give them great anti and non-pick
properties which can be invaluable in settings like
prisons and even schools. Ordinary sanitary sealants
such as silicones just can’t compete.
Read the full article on Hodgson
Sealants website here.
Beneting from inbuilt BioCote® Antimicrobial
Technology, our latest-generation hybrid sealant
HY-SPEC® Ag has a ground-breaking antimicrobial
formulation designed to ght bacteria and other
microbes to uphold a fully hygienic environment.
Our antimicrobial sealants have BioCote® additives that
are designed to have a negative eect on any
contaminating microbes causing them to reduce and it
does this in a number of clever ways:
• Protein damage: Proteins are essential for the
biological systems of life. Any damage to these
components causes the failure of essential functions
such as energy production.
• Cell membrane damage: By disrupting the microbes
membrane, its structural integrity is compromised,
which can cause essential nutrients to leak out and
catastrophic structural failure of the microbe.
www.basa.uk.com BASA BULLETIN Issue 91 | 11
    


The Sealant team remains the same, so our clients
will still deal directly with Lesley and Paula and their
team.
The Laboratory is a UKAS Accredited Testing
Laboratory No 0307, operating to ISO 17025:2017
Quality System.
As of 1st January we are now a UK Approved body
AVCP3 (No. 2538) for BS EN 15651 Parts 1-4 (latest
edition) Sealants for non-structural joints in
Buildings and Pedestrian walkways and BS EN 12004
Parts 1-2 (latest edition) Adhesives for ceramic tiles.
This means we can test your product of the new
UKCA mark, but we also continue to be a Notied
Body for CE testing for these products for Northern
Ireland. For any further information please go to
gov.uk
An example of a PVA test to BS 5270 Part 1:1989
Bond test is shown below.
    
      
    

      
      
     
       


| BASA BULLETIN Issue 91 www.basa.uk.com



A £9,000 cash pot earmarked by Construction Products
Group (CPG) UK for Christmas celebrations has been
given to a community project to support the
vulnerable and disadvantaged over the festive period.
CPG UK has donated its Christmas fund to The Brick – a
charity which works with people facing crisis across
Wigan, where the company has its headquarters.
The Brick will use the cash to help ensure no-one in the
borough is left to struggle over the festive period.
Keely Dalfen, Commercial and Finance Director at The
Brick said: The Covid-19 pandemic has hit the most
vulnerable and disadvantaged people and
communities in Wigan and Leigh the hardest, which
has created unprecedented additional demand and
pressure on our services.
“We are delighted to be able to step up to the
challenge with the help of this generous donation from
CPG UK.
“The funds will ensure that we can continue to reach
out to everyone who needs us and that no-one is left
behind this Christmas.
CPG UK is renowned for its building products brands
including illbruck, Flowcrete, Tremco, Vandex, Dryvit
and Nudura, as well as Nullire - which oer re
protection, sealing, bonding, insulation, ooring,
waterproong and roong solutions.
John Gordon, Managing Director at CPG UK, said:
We’ve pooled together money allocated for customer
gifts, entertaining and other Christmas celebrations
and instead donated it to The Brick.
Together, the team at CPG UK decided on a Wigan
charity as it is where our main UK manufacturing
facility is based, and to also celebrate the fact that our
site is undergoing a major redevelopment.
We’ve been manufacturing on this site since 1985 and
we are currently going through a multi-million-pound
investment to modernise and increase capacity at the
facility.
“These investments will not only improve eciency
but will also create new employment opportunities for
local people.
“The Brick does an incredible job and this year, more
than ever, they face a challenging task to support the
community.
“Its team of sta and volunteers provide outreach
support for people living on the streets and provide a
network of emergency accommodation and support
packages to help people on their journey into a
permanent home and sustainable future.
The team at CPG UK is delighted to see this money
allocated to such a great cause.
Part of leading global company RPM, as well as its main
UK manufacturing facility in Wigan, CPG UK has ve
further sites in Cheshire, Coventry, Leicester, Kent and
Hertfordshire, employing almost 300 people
nationwide.
The company is on a growth curve, with 65 new
people recruited to key roles in 2020, reecting the
success of its innovative approach, sustainable
solutions, rst-class technology and customer-focused
approach, along with skills that have been built-up
over multiple decades within very specialised elds.

www.basa.uk.com BASA BULLETIN Issue 91 | 13
According to JOC.com, COVID-19 is upending
global container volume demand and rippling
through containerized supply chains. They go
on to report that this is sending shockwaves to
all freight transport modes, from trucking to air
cargo.
Carriers, forwarders, port authorities, and marine
terminals are warning of a cargo bottleneck if
more Western importers fail to pick up
containers when they arrive, causing port
congestion and inland equipment shortages
that will slow down the broader supply chain.
Read more here:







| BASA BULLETIN Issue 91 www.basa.uk.com


Members of: FEICA • Trade Association Forum • Alliance of Chemical Associations
Society of Adhesion & Adhesives • BSI • UK Food Paper Packaging Chain • The Construction Products Association
BASA Bulletin Online is our online only newsletter for the British
and Irish Adhesives and Sealants Association, to keep members
updated inbetween our two yearly printed bulletins. Thank you to
members for your company stories and please continue to send us
your news which we will share accross our media platforms.
24 Laurel Close
Ely, Cambridgeshire, CB6 2BN
Tel: +44 3302 233290
www.basa.uk.com
Bondloc UK Ltd, a leading British manufacturer of
industrial adhesives and sealants for over 25 years, is
proud to announce its Quality Management System
(QMS) has been recertiÿed to ISO 9001:2015 after a
comprehensive audit during January 2021.
Quality Manager, Gary Taylor said: This is an
important certiÿcation by a worldwide recognised
authority on quality management and conÿrms that
our processes continue to be robust ensuring we
deliver consistent, world-class quality products to our
customers.
“Our adhesive products are used in the most
demanding engineering and manufacturing
applications across automotive, construction,
agricultural, marine and transport industries where
service and the quality of products used is of utmost
paramount to their manufacturing and engineering
processes.
Mark Adams, managing director said: “2020 was a
challenging year, and its been business “not as usual”,
but we’ve continued to operate a COVID safe
workplace and support customers needs thanks to
our fantastic sta° who have adapted well to new ways
of working. We wanted to start 2021 with a positive
and strong foundation and this recertiÿcation re˛ec ts
our commitment to continual improvement and
on-going quality assurance to our customers.
We have ambitious plans and strong projected
growth for this year, and we are investing further in
our production capabilities to support increased
demand and to drive manufacturing productivity.
Sales and Marketing
Director, Paul Nelson
said: With the onset
of Brexit and various
supply issues with
imported goods, we
are already seeing
OEMs looking to
switch their adhesive
products for UK
made, high-quality
but lower-cost local
alternatives. Our
chemists work closely
with the project teams on sampling and testing to
ensure a smooth production transition. ISO
9001:2015 underpins our customers’ conÿdence in
our quality systems to aid this process.
For more information contact our technical team to
discuss your bonding projects and potential cost
savings on 01299 269269 or email
sales@bondloc.co.uk
Support British Manufacturing.